YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 3.08 USD -8.06% Market Closed
Market Cap: 58.8m USD
Have any thoughts about
YS Biopharma Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
YS Biopharma Co Ltd

Current Assets 903.2m
Cash & Short-Term Investments 246.4m
Receivables 444.2m
Other Current Assets 212.7m
Non-Current Assets 609.9m
PP&E 480.6m
Intangibles 71.2m
Other Non-Current Assets 58m
Current Liabilities 802.2m
Accounts Payable 67.8m
Accrued Liabilities 413.9m
Other Current Liabilities 320.6m
Non-Current Liabilities 125.6m
Long-Term Debt 99m
Other Non-Current Liabilities 26.6m

Balance Sheet
YS Biopharma Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
271
370
246
Cash
271
370
246
Short-Term Investments
3
4
4
Total Receivables
313
468
447
Accounts Receivables
309
463
444
Other Receivables
4
5
3
Inventory
167
185
203
Other Current Assets
12
8
2
Total Current Assets
765
1 036
903
PP&E Net
565
583
481
PP&E Gross
565
583
481
Accumulated Depreciation
180
209
316
Intangible Assets
81
78
71
Other Long-Term Assets
31
23
58
Total Assets
1 442
N/A
1 720
+19%
1 513
-12%
Liabilities
Accounts Payable
31
80
68
Accrued Liabilities
228
266
281
Short-Term Debt
0
0
0
Current Portion of Long-Term Debt
112
194
319
Other Current Liabilities
106
118
135
Total Current Liabilities
476
659
802
Long-Term Debt
254
294
99
Other Liabilities
41
39
27
Total Liabilities
771
N/A
991
+29%
928
-6%
Equity
Common Stock
1 370
0
0
Retained Earnings
1 591
1 874
2 308
Additional Paid In Capital
809
2 657
2 951
Other Equity
83
54
58
Total Equity
671
N/A
728
+9%
585
-20%
Total Liabilities & Equity
1 442
N/A
1 720
+19%
1 513
-12%
Shares Outstanding
Common Shares Outstanding
93
93
190

See Also

Discover More